ACTIN BASED MOTILITY BY RICKETTSIA RICKETTSII

立克次体 RICKETTSII 基于肌动蛋白的运动

基本信息

  • 批准号:
    6373895
  • 负责人:
  • 金额:
    $ 23.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-06-15 至 2003-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from the applicant's abstract): Spotted fever group (SFG) rickettsiae are the etiologic agents of serious human diseases including Rocky Mountain spotted fever, caused by Rickettsia rickettsii. Because of limitations imposed by the lack of workable genetic systems and the necessity of using eucaryotic cells as a growth medium, there is a paucity of information on specific virulence mechanisms exploited by these organisms. Insight into the virulence of SFG rickettsiae has recently been achieved with the discovery that, upon entering the cytoplasmic compartment, organisms recruit and polymerize host cell actin to promote direct cell-to-cell spread. To achieve a greater understanding of rickettsial actin-based motility, the research conducted in this proposal has the following goals: 1) identify the rickettsial protein ligand(s) that mediates actin-based motility and the cognate cytosolic proteins that bind this ligand(s), and 2) fully characterize rickettsial actin tail structure and formation. A priori, the rickettsial protein involved in actin recruitment is likely surface localized. Therefore, aim 1 will focus upon the potential involvement of the two immunodominant rickettsial outer membrane proteins, rOmpA and rOmpB. Transfected Vero cells producing specific domains of rOmpA or rOmpB, and infected with R. rickettsii, will be examined to determine whether cytosolic rOmp domain expression disrupts rickettsial actin recruitment and/or host cell microfilament structure. A parallel approach will utilize microinjection of rOmpA or rOmpB-specific Mab into the cytoplasm of infected cells to determine if rickettsial-induced actin polymerization can be inhibited. Because a rickettsial surface protein other than rOmpA and rOmpB may be involved, a global screen of rickettsial small-plaque-forming mutants generated by UV irradiation will be conducted in aim 2 to identify rickettsial mutants deficient for actin mobilization. The protein profiles of mutant and wild type rickettsiae will be compared to identify and allow molecular cloning of the candidate rickettsial actin recruitment protein. Aim 3 will identify and clone host cytosolic proteins that interact with the identified rickettsial actin recruitment protein. Interacting host proteins will initially be identified as proteins that co-immunoprecipitate with the rickettsial protein produced in Vero cells by transfection. Affinity chromatography will be performed with cytoplasmic extracts to purify the interacting host protein and allow identification and cloning of the encoding gene. A separate strategy will employ yeast-two hybrid technology. Finally, aim 4 will examine rickettsial actin tails to identify actin filament length and orientation, associated host actin-binding proteins, and the relative rate of rickettsial actin-based movement. Not only will these studies lead to a greater understanding of molecular mechanisms of rickettsial pathogenesis, but they will also provide insight into the dynamic control of actin polymerization.
描述(改编自申请人摘要):斑疹热组

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert A. Heinzen其他文献

Morphological remodeling of emCoxiella burnetii/em during its biphasic developmental cycle revealed by cryo-electron tomography
通过冷冻电子断层扫描揭示伯氏考克斯体在其两相发育周期中的形态重塑
  • DOI:
    10.1016/j.isci.2023.107210
  • 发表时间:
    2023-07-21
  • 期刊:
  • 影响因子:
    4.100
  • 作者:
    Doulin C. Shepherd;Mohammed Kaplan;Naveen Vankadari;Ki Woo Kim;Charles L. Larson;Przemysław Dutka;Paul A. Beare;Edward Krzymowski;Robert A. Heinzen;Grant J. Jensen;Debnath Ghosal
  • 通讯作者:
    Debnath Ghosal
Use of Pulsed Field Gel Electrophoresis to Differentiate Coxiella burnetii Strains a
使用脉冲场凝胶电泳区分伯氏柯克斯体菌株
  • DOI:
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Robert A. Heinzen;Robert A. Heinzen;G. L. Stiegler;L. L. Whiting;S. A. Schmitt;L. Mallavia;M. E. Frazier
  • 通讯作者:
    M. E. Frazier
Strategy for Detection and Differentiation of Coxiella bumetii Strains Using the Polymerase Chain Reactiona a
使用聚合酶链式反应检测和区分布美柯克斯体菌株的策略 a
  • DOI:
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    L. Mallavia;L. L. Whiting;Michael F. Minnick;Robert A. Heinzen;Robert A. Heinzen;M. Foreman;Oswald G. Baca;M. E. Frazier
  • 通讯作者:
    M. E. Frazier

Robert A. Heinzen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert A. Heinzen', 18)}}的其他基金

ACTIN BASED MOTILITY BY RICKETTSIA RICKETTSII
立克次体 RICKETTSII 基于肌动蛋白的运动
  • 批准号:
    2680507
  • 财政年份:
    1998
  • 资助金额:
    $ 23.53万
  • 项目类别:
ACTIN BASED MOTILITY BY RICKETTSIA RICKETTSII
立克次体 RICKETTSII 基于肌动蛋白的运动
  • 批准号:
    2887805
  • 财政年份:
    1998
  • 资助金额:
    $ 23.53万
  • 项目类别:
ACTIN BASED MOTILITY BY RICKETTSIA RICKETTSII
立克次体 RICKETTSII 基于肌动蛋白的运动
  • 批准号:
    6170555
  • 财政年份:
    1998
  • 资助金额:
    $ 23.53万
  • 项目类别:
ACTIN BASED MOTILITY BY RICKETTSIA RICKETTSII
立克次体 RICKETTSII 基于肌动蛋白的运动
  • 批准号:
    6510869
  • 财政年份:
    1998
  • 资助金额:
    $ 23.53万
  • 项目类别:

相似海外基金

Rocky Mountain Spotted Fever Vaccine Development
落基山斑疹热疫苗开发
  • 批准号:
    10477183
  • 财政年份:
    2021
  • 资助金额:
    $ 23.53万
  • 项目类别:
Rocky Mountain Spotted Fever Vaccine Development
落基山斑疹热疫苗开发
  • 批准号:
    9998279
  • 财政年份:
    2021
  • 资助金额:
    $ 23.53万
  • 项目类别:
Rocky Mountain Spotted Fever Vaccine Development
落基山斑疹热疫苗开发
  • 批准号:
    10675538
  • 财政年份:
    2021
  • 资助金额:
    $ 23.53万
  • 项目类别:
Rocky Mountain Spotted Fever Vaccine Development
落基山斑疹热疫苗开发
  • 批准号:
    10814647
  • 财政年份:
    2021
  • 资助金额:
    $ 23.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了